Business & Economy
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Source: Business News · Published
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Related stories
Nvidia’s value tumbles by $330bn after ‘honeytrap’ investigation launched, as China denies spying claims – business live
Boss of world’s most valuable company admits affair as it investigates reports he was the target of ‘a foreign intelligence effort’ Nvidia opens investigation after report CEO Jensen Huang was target of foreign intelligence Huang is receiving support from some fellow tech executi
Business | The Guardian ·
Goodyear Tire CEO Mark Stewart steps down as company continues turnaround plan
Goodyear Tire & Rubber appointed board member Roger Wood interim CEO and president, replacing Mark Stewart as the tire maker continues its turnaround plan.
Business News ·
Rising cost of living tests UK's net zero ambitions
From floods to wildfires to heatwaves, 2026 is the year it became hard to ignore the impact of climate change on UK weather. But will soaring living costs affect the government’s commitment to tackling climate change?
feeds.bbci.co.uk ·
Why is Nvidia’s Jensen Huang at the centre of a US-China row?
Donald Trump praised the chipmaker’s CEO despite reports he had an affair with a suspected Chinese spy Nvidia has launched an investigation into allegations that its chief executive, Jensen Huang, has been the target of a Chinese espionage operation . Huang has admitted to having
Business | The Guardian ·
Government's EV targets expected to be reduced this week
New petrol or diesel cars are due to be phased out by 2030 and by 2035 all new cars must be zero emission.
feeds.bbci.co.uk ·